| LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins WQ Wei, X Li, Q Feng, M Kubo, IJ Kullo, PL Peissig, EW Karlson, ... Circulation 138 (17), 1839-1849, 2018 | 96 | 2018 |
| Harmonizing clinical sequencing and interpretation for the eMERGE III network H Zouk, E Venner, NJ Lennon, DM Muzny, D Abrams, S Adunyah, ... The American Journal of Human Genetics 105 (3), 588-605, 2019 | 93 | 2019 |
| Returning results in the genomic era: initial experiences of the eMERGE Network GL Wiesner, A Kulchak Rahm, P Appelbaum, S Aufox, ST Bland, CL Blout, ... Journal of Personalized Medicine 10 (2), 30, 2020 | 50 | 2020 |
| Returning integrated genomic risk and clinical recommendations: The eMERGE study JE Linder, A Allworth, HT Bland, PJ Caraballo, RL Chisholm, EW Clayton, ... Genetics in Medicine 25 (4), 100006, 2023 | 43 | 2023 |
| Association of pathogenic variants in hereditary cancer genes with multiple diseases C Zeng, LA Bastarache, R Tao, E Venner, S Hebbring, JD Andujar, ... JAMA oncology 8 (6), 835-844, 2022 | 26 | 2022 |
| Arrhythmia variant associations and reclassifications in the eMERGE-III sequencing study AM Glazer, G Davogustto, CM Shaffer, CG Vanoye, RR Desai, ... Circulation 145 (12), 877-891, 2022 | 18 | 2022 |
| Understanding the return of genomic sequencing results process: Content review of participant summary letters in the eMERGE research network JA Lynch, RR Sharp, SA Aufox, ST Bland, C Blout, DJ Bowen, ... Journal of personalized medicine 10 (2), 38, 2020 | 17 | 2020 |
| The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network KA Leppig, AK Rahm, P Appelbaum, S Aufox, HT Bland, A Buchanan, ... Genetics in Medicine 24 (5), 1130-1138, 2022 | 16 | 2022 |
| Ethical conflicts in translational genetic research: lessons learned from the eMERGE-III experience CME Halverson, HT Bland, KA Leppig, M Marasa, M Myers, HM Rasouly, ... Genetics in Medicine 22 (10), 1667-1672, 2020 | 13 | 2020 |
| Phenotyping coronavirus disease 2019 during a global health pandemic: Lessons learned from the characterization of an early cohort S DeLozier, HT Bland, M McPheeters, Q Wells, E Farber-Eger, CA Bejan, ... Journal of Biomedical Informatics 117, 103777, 2021 | 11 | 2021 |
| Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scores JJ Connolly, ES Berner, M Smith, S Levy, S Terek, M Harr, D Karavite, ... Genetics in Medicine 25 (9), 100906, 2023 | 6 | 2023 |
| Returning negative results from large‐scale genomic screening: Experiences from the eMERGE III network KS Finn, J Lynch, S Aufox, HT Bland, W Chung, C Halverson, S Hebbring, ... American Journal of Medical Genetics Part A 185 (2), 508-516, 2021 | 6 | 2021 |
| Genetic sex validation for sample tracking in next-generation sequencing clinical testing J Hu, V Korchina, H Zouk, MV Harden, D Murdock, A Macbeth, ... BMC Research Notes 17 (1), 62, 2024 | 1 | 2024 |
| Conducting inclusive research in genetics for transgender, gender‐diverse, and sex‐diverse individuals: Case analyses and recommendations from a clinical genomics study HT Bland, MJ Gilmore, J Andujar, MA Martin, N Celaya‐Cobbs, ... Journal of Genetic Counseling, 2023 | 1 | 2023 |
| Protecting Privacy of Pregnant and LGBTQ+ Research Participants EW Clayton, HT Bland, KF Mittendorf JAMA, 2024 | | 2024 |
| P496: Predictors of genetic counseling uptake when using a family health history platform for hereditary cancer risk A Sadeghpour, R Myers, M Gerhart, N Celaya-Cobbs, H Bland, J Andujar, ... Genetics in Medicine Open 2, 2024 | | 2024 |
| Genetic Sex Validation for Sample Tracking in Clinical Testing J Hu, V Korchina, H Zouk, MV Harden, D Murdock, A Macbeth, ... Research Square, 2023 | | 2023 |
| eP489: Exploring engagement and uptake of a comprehensive family history-based cancer risk assessment tool M Hubert, G Hooker, S Bland, N Celaya-Cobbs, J Andujar, L Orlando, ... Genetics in Medicine 24 (3), S311-S312, 2022 | | 2022 |
| eP506: Implementing diverse community engagement studios: The Family History and Cancer Risk Study (FOREST) at Vanderbilt and Meharry Medical College S Pratap, D Marshall, S Bland, S Jones, L Orlando, L Alexander, J Duke, ... Genetics in Medicine 24 (3), S322-S323, 2022 | | 2022 |
| A scalable EHR-based approach for phenotype discovery and variant interpretation for hereditary cancer genes C Zeng, LA Bastarache, R Tao, E Venner, S Hebbring, JD Andujar, ... medRxiv, 2021.03. 18.21253763, 2021 | | 2021 |
Dan RodenProfessor of Medicine, Pharmacology, and Biomedical Informatics, Vanderbilt University Medical CtrVerified email at vanderbilt.edu
